ClinicalTrials.Veeva

Menu

Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars

B

British University In Egypt

Status

Unknown

Conditions

Pulp Disease, Dental

Treatments

Procedure: Direct Pulp Capping
Procedure: Partial Pulpotomy
Procedure: Pulpotomy

Study type

Interventional

Funder types

Other

Identifiers

NCT05102318
Ain Shams University

Details and patient eligibility

About

The aim of the present study is to evaluate Mineral Trioxide Aggregate and Biodentine in direct pulp capping, partial pulpotomy, and pulpotomy in primary molars.

Full description

Screening of patients will continue until the target population is achieved. Identifying and recruiting potential subjects is achieved through patient database in Pediatric Dentistry department.

A total of 150 primary molars from healthy subjects will be selected from the Pediatric Dentistry and Dental Public Health outpatient clinic, Faculty of Dentistry, Ain shams University.

Subjects will be assigned randomly into two different treatment groups as follows:

MTA Group (1):

  1. Group 1(A): MTA Direct Pulp Capping. (n=25)
  2. Group 1 (B): MTA Partial Pulpotomy. (n=25)
  3. Group 1 (C): MTA Complete Pulpotomy. (n=25)

BiodentineTM Group (2):

  1. Group 2(A): BiodentineTM Direct Pulp Capping. (n=25)
  2. Group 2 (B): BiodentineTM Partial Pulpotomy. (n=25)
  3. Group 2 (C): BiodentineTM Complete Pulpotomy. (n=25)

Enrollment

150 estimated patients

Sex

All

Ages

4 to 7 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • No clinical symptoms or history implying irreversible pulpitis such as spontaneous pain, or pain persisting after stimuli removal.
  • Absence of periapical or interadicular radiolucencies, inflammatory root resorption, sinus tract or gingival abscess.

Exclusion criteria

  • Children who are extremely uncooperative and difficult to manage.
  • Children suffering from any physically or mentally disability that will complicate the treatment: Special Health Care needs (SHCN).
  • Teeth of poor prognosis due to presence of an abscess or a sinus, mobility, advanced bone or root resorption or Non-Restorable teeth.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

150 participants in 6 patient groups

Direct Pulp Capping with Biodentine
Experimental group
Description:
Direct Pulp Capping with Biodentine
Treatment:
Procedure: Direct Pulp Capping
Partial Pulpotomy with Biodentine
Experimental group
Description:
Partial Pulpotomy with Biodentine
Treatment:
Procedure: Partial Pulpotomy
Pulpotomy with Biodentine
Experimental group
Description:
Pulpotomy with Biodentine
Treatment:
Procedure: Pulpotomy
Direct Pulp Capping with MTA
Experimental group
Description:
Direct Pulp Capping with MTA
Treatment:
Procedure: Direct Pulp Capping
Partial Pulpotomy with MTA
Experimental group
Description:
Partial Pulpotomy with MTA
Treatment:
Procedure: Partial Pulpotomy
Pulpotomy with MTA
Experimental group
Description:
Pulpotomy with MTA
Treatment:
Procedure: Pulpotomy

Trial contacts and locations

1

Loading...

Central trial contact

Nadia Metwalli, Professor; Marwa Magdy, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems